At a glance
- Originator NeuroSearch
- Class Antidementias; Benzimidazoles; Neuroprotectants; Piperidines; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Neurological disorders
Most Recent Events
- 09 Nov 1999 Preclinical development for Neurological disorders (Prevention) in Denmark (Unknown route)